Skip to results
Modify your search
NARROW
1-20 of 195
Authors: Silvio Danese
Journal Article
ACCEPTED MANUSCRIPT
Deucravacitinib in Patients With Inflammatory Bowel Disease: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn’s Disease and Ulcerative Colitis Open Access
Journal of Crohn's and Colitis, jjaf080, https://doi.org/10.1093/ecco-jcc/jjaf080
Published: 13 May 2025
Journal Article
Comparing Outcomes With Subcutaneous Infliximab (CT-P13 SC) by Baseline Immunosuppressant Use: A Post Hoc Analysis of the LIBERTY-CD and LIBERTY-UC Studies Open Access
Inflammatory Bowel Diseases, izaf038, https://doi.org/10.1093/ibd/izaf038
Published: 30 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Crohn’s Disease and Ulcerative Colitis: 2-Year Results from Open-Label Extensions of Two Randomized Controlled Trials (LIBERTY) Get access
Journal of Crohn's and Colitis, jjaf060, https://doi.org/10.1093/ecco-jcc/jjaf060
Published: 17 April 2025
Journal Article
Assessment and Impact of Age on the Safety and Efficacy of Etrasimod in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From the ELEVATE UC Clinical Program Open Access
Inflammatory Bowel Diseases, izae308, https://doi.org/10.1093/ibd/izae308
Published: 04 April 2025
Journal Article
TWO-YEAR RESULTS OF SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) DOSE ESCALATION THERAPY - FROM LIBERTY-CD AND LIBERTY-UC Free
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Page S13, https://doi.org/10.1093/ibd/izae282.029
Published: 28 February 2025
Journal Article
TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WITH RO7790121 DEMONSTRATES EARLY CLINICAL RESPONSE AND SYMPTOM IMPROVEMENT – RESULTS FROM THE PHASE 2B TUSCANY-2 TRIAL Free
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Page S12, https://doi.org/10.1093/ibd/izae282.028
Published: 28 February 2025
Journal Article
IMPACT OF IMMUNOGENICITY ON CLINICAL OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING MAINTENANCE TREATMENT WITH SUBCUTANEOUS INFLIXIMAB: A POST HOC ANALYSIS OF THE LIBERTY-UC STUDY Free
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Page S9, https://doi.org/10.1093/ibd/izae282.023
Published: 28 February 2025
Journal Article
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference Open Access
Inflammatory Bowel Diseases, izaf013, https://doi.org/10.1093/ibd/izaf013
Published: 11 February 2025
Journal Article
Assessment of activity and severity of inflammatory bowel disease in cross-sectional imaging techniques: a systematic review Get access
Journal of Crohn's and Colitis, Volume 19, Issue 2, February 2025, jjaf023, https://doi.org/10.1093/ecco-jcc/jjaf023
Published: 04 February 2025
Journal Article
Systematic review on definitions of intestinal ultrasound treatment response and remission in inflammatory bowel disease Get access
Journal of Crohn's and Colitis, Volume 19, Issue 2, February 2025, jjaf011, https://doi.org/10.1093/ecco-jcc/jjaf011
Published: 18 January 2025
Journal Article
Multiple Ileal and Colonic Stenoses: Is It Always Crohn’s Disease? Open Access
Journal of Crohn's and Colitis, Volume 19, Issue 5, May 2025, jjae174, https://doi.org/10.1093/ecco-jcc/jjae174
Published: 16 December 2024
Journal Article
Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION Study Open Access
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1095–1108, https://doi.org/10.1093/ibd/izae278
Published: 04 December 2024
Journal Article
Reply: MIND the Gap: Psychiatric Conditions in Inflammatory Bowel Disease Get access
Inflammatory Bowel Diseases, Volume 31, Issue 3, March 2025, Pages 897–898, https://doi.org/10.1093/ibd/izae258
Published: 05 November 2024
Journal Article
Upadacitinib in Patients With Difficult-to-Treat Crohn’s Disease Open Access
Crohn's & Colitis 360, Volume 6, Issue 4, October 2024, otae060, https://doi.org/10.1093/crocol/otae060
Published: 24 October 2024
Journal Article
Review: Risk Stratification of Patients With Ulcerative Colitis for Treatment With Tofacitinib Open Access
Crohn's & Colitis 360, Volume 6, Issue 4, October 2024, otae049, https://doi.org/10.1093/crocol/otae049
Published: 19 September 2024
Journal Article
Prevalence, Characteristics, Management, and Outcomes of Difficult-to-Treat Inflammatory Bowel Disease Get access
Journal of Crohn's and Colitis, Volume 19, Issue 3, March 2025, jjae145, https://doi.org/10.1093/ecco-jcc/jjae145
Published: 12 September 2024
Journal Article
The Burden of Psychiatric Manifestations in Inflammatory Bowel Diseases: A Systematic Review With Meta-analysis Get access
Inflammatory Bowel Diseases, Volume 31, Issue 5, May 2025, Pages 1441–1459, https://doi.org/10.1093/ibd/izae206
Published: 12 September 2024
Journal Article
630. ENDOSCOPIC MANAGEMENT OF DELAYED-GASTRIC-EMPTYING AFTER ESOPHAGECTOMY IN A TERTIARY REFERRAL CENTER: COMPARISON BETWEEN DIFFERENT ENDOSCOPIC PROCEDURES Free
Diseases of the Esophagus, Volume 37, Issue Supplement_1, September 2024, doae057.336, https://doi.org/10.1093/dote/doae057.336
Published: 02 September 2024
Journal Article
Standard length of peroral endoscopic myotomy (POEM) for achalasia: a systematic review and meta-analysis Open Access
Diseases of the Esophagus, Volume 37, Issue 12, December 2024, doae069, https://doi.org/10.1093/dote/doae069
Published: 30 August 2024
Journal Article
Nested Randomized Controlled Trials in Large Databases: An Opportunity for Inflammatory Bowel Disease? Free
Journal of Crohn's and Colitis, Volume 19, Issue 2, February 2025, jjae136, https://doi.org/10.1093/ecco-jcc/jjae136
Published: 29 August 2024
